Our Story
What We do
Antigenesis is a biotech company dedicated to addressing critical unmet needs in veterinary medicine. Leveraging our expertise in human therapeutics, we bring state-of-the-art advances to the significantly underserved veterinary market. Using AI/ML and cutting-edge biologics, we develop targeted, safe, and effective treatments for oncology and other serious conditions. Our mission is to accelerate innovation and improve the health and well-being of our animal family members.
At our core is a simple belief: animals deserve access to the same cutting-edge care as humans and we’re here to make that a reality.
Our Vision
To revolutionise veterinary medicine by providing targeted therapies that extend the lives of companion animals and improve their quality of life.
Our Mission
At Antigenesis, we are dedicated to developing first-in-class antibody therapeutics that address critical unmet needs in veterinary medicine. By building on proven human immunotherapies and leveraging advanced AI/ML technology, we aim to deliver innovative, life-saving treatments for our animal family members, starting with oncology and expanding to broader indications. We strive to bring faster, more effective treatments to market with reduced risks and costs, ultimately transforming veterinary medicine and the way currently life-limiting conditions are treated in companion animals.
Our Purpose
Our purpose is to harness the power of biotechnology to improve and extend lives for our animal companions. We are committed to delivering targeted, innovative therapeutics that address some of the most challenging health conditions, driving positive change in veterinary medicine. Through responsible innovation, rigorous science, and a focus on ethical development, we are shaping the future of healthcare and improving the lives of those who depend on it.